A new study has identified the enzyme NADPH oxidase 4 (NOX4) as a critical regulator of the body’s ability to adapt to exercise during aging, offering fresh insights into the biological processes behind age-related muscle loss and reduced physical resilience.

Loss of muscle mass and strength, known as sarcopenia, is a common consequence of aging that contributes to frailty, impaired mobility, metabolic dysfunction, and increased risk of chronic disease. Beyond enabling movement, skeletal muscle plays an essential role in regulating metabolism, including insulin sensitivity, making the preservation of muscle health an important factor in healthy aging.

Researchers report that declining levels of NOX4 in aging skeletal muscle impair the body’s natural adaptive response to exercise. While regular physical activity stimulates muscle growth and repair in younger individuals, these beneficial adaptations become less effective with age. The findings suggest that reduced NOX4 activity is a significant contributor to this diminished response.

The study explains that exercise increases energy production within muscle cells, leading to the temporary generation of reactive oxygen species (ROS). Although excessive ROS can damage proteins, lipids, and DNA, controlled amounts serve as important signaling molecules that activate protective cellular pathways. NOX4 plays a central role in producing these signaling molecules, particularly hydrogen peroxide (H₂O₂), which triggers adaptive responses that strengthen muscle tissue.

As NOX4 levels decline with age, this protective signaling weakens, resulting in reduced activation of the NFE2L2 pathway, a key regulator of the body’s antioxidant defenses. Consequently, aging muscles experience greater oxidative damage, impaired repair mechanisms, and declining function despite continued physical activity.

Using aged mice and human muscle samples, researchers found that NOX4 levels decrease significantly over time. Mice lacking NOX4 specifically in skeletal muscle exhibited accelerated age-related decline, including severe muscle wasting, reduced physical activity, increased body fat, systemic inflammation, insulin resistance, and advanced liver disease.

Importantly, the researchers demonstrated that restoring NOX4 activity through gene therapy approaches or activating the downstream NFE2L2 pathway using the naturally occurring compound sulforaphane significantly improved muscle function and restored many of the protective adaptations normally induced by exercise.

The findings highlight NOX4 as a promising therapeutic target for combating age-related muscle decline and improving the effectiveness of exercise in older adults. By restoring adaptive homeostasis, the body’s ability to respond to physiological stress, future interventions may help preserve muscle health, reduce frailty, and support healthier aging.

The study provides new evidence that age-related reductions in exercise responsiveness are not solely the result of accumulated tissue damage but also stem from changes in molecular signaling pathways that regulate the body’s natural defense and repair mechanisms. Researchers believe that therapies aimed at restoring these pathways could complement exercise-based interventions and help maintain physical function later in life.